SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Samuel Johnson

PatientSamuel Johnson
Date of birth1970-09-18
IdentifiersMRN HR-EN008-SYN; SSN (made up) 000-08-7139
Document date2026-06-22
AuthorCatriona Bell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eleven-week review of depression and tics. [S]

History of Present Illness

Mr. Johnson returns five weeks after sertraline was increased to 100 mg. He is writing most mornings again and dines with friends several times a week. He wakes less often in dread. He has mild night sweats and no other side effects. He has had six of eight sessions of behavioral therapy for tics and uses the competing response for the head-shaking tic in company; the clucking sounds are less frequent. There was no check two weeks after the dose increase. [S]

ElementDetail
Sertraline100 mg daily for five weeks
MoodPHQ-9 10
FunctionWriting most mornings; seeing friends
Tic therapySix of eight sessions
Side effectsMild night sweats

Review of Systems

SystemResultFinding
ConstitutionalPositiveMild night sweats; no fever or weight loss
NeurologicalPositiveTics less frequent
PsychiatricNegativeMood much better; no thoughts of suicide or self-harm

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-04-06 to 2026-05-18completedS
Sertraline 100 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-22Body height183cmS
2026-06-22Body weight98.6kgS
2026-06-22Body mass index (BMI) [Ratio]29.4kg/m2S
2026-06-22Systolic blood pressure124mm[Hg]S
2026-06-22Diastolic blood pressure78mm[Hg]S
2026-06-22Heart rate76/minS
2026-06-22Respiratory rate14/minS
2026-06-22Body temperature36.6CelS
2026-06-22Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S

Physical Exam

Vital signs recorded on 2026-06-22; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 124/78, pulse 76
NeurologicalFewer head-turning tics and sounds during the visit
PsychiatricBrighter; humorous and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholyactiveconfirmed F33.2S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health.
Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requestedresolvedconfirmed F95.9S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation.
Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosisactiveconfirmed F95.2S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact.
Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eyeactiveconfirmed H54.42S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyDepression measure (PHQ-9)At baseline and at least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today10: response, not yet remission
Medication safetySertraline adherence and adverse effectsEvery visit in the acute phase; reassess at 2 weeks after starting and after each dose changeCompleted todayMild night sweats; adherent
Medication safetyReassessment two weeks after the sertraline dose increaseTwo weeks after each dose changeDeferredProtocol deviation: no check two weeks after the increase to 100 mg; the next contact was today, five weeks later. No harm resulted: no activation, no new suicidal thoughts, and PHQ-9 fell to 10. Corrective action: a nurse phone check two weeks after any future dose change
SurveySuicide-risk review (PHQ-9 item 9 and structured questions since the last visit), safety plan, and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm
ReferralPsychotherapy (cognitive behavioral therapy with behavioral activation)Offer to all with moderate or severe depressionCompleted todayTen sessions; now every two weeks
SurveyAnxiety measure (GAD-7)At baseline and with PHQ-9 reviewsUp to date9 five weeks ago
SurveyTic severity (Yale Global Tic Severity Scale, recorded in the note; no LOINC code is used)At diagnosis and periodically to judge the need for and response to treatmentCompleted todayTotal tic score 26; impairment 10
ReferralComprehensive Behavioral Intervention for TicsOffer as an initial treatment optionCompleted todaySix of eight sessions
Medication safetyTic-suppressing medication (alpha-2 agonist, aripiprazole, or other)When tics cause impairment that behavioral therapy does not relieveNot indicatedNot needed

Goal progress:

Guideline basis: Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders (Pringsheim T, et al. Neurology 2019;92(19):896-906) (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Preventive visit in five weeks. Six-month review in the autumn. Next scheduled visit 2026-07-27: periodic adult preventive visit. [S]